CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML

Clinical trial NCT04787263 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04787263
Sponsor: Bambino Gesù Hospital and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma Primary Mediastinal Lymphoma

Start date: 2021-03-04
Primary completion: 2027-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.